Complaints about Gilead Sciences' Truvada are part of a wave of anger over drug companies reaping hefty financial rewards by capitalizing on taxpayer-funded research.
. To get close to that goal, specialists say, Truvada for PrEP needs to be far more widespread. Trump’s newest budget, released this month, would add $291 million to fight the disease.
After Truvada was shown to work as a prophylactic in primates, the CDC applied for its patents. That began a nine-year effort, using two outside law firms retained by the CDC, which made their case to U.S. Patent and Trademark Office examiners. Gilead often works in cooperation with federal research agencies because it seeks to develop drugs to fight infectious diseases such as HIV/AIDS, hepatitis B and hepatitis C, epidemics that have attracted intense government attention. But it also has been criticized for excessive pricing; in 2013, it sparked an uproar when it priced a 12-week course of theHIV/AIDS activists have been upset about the price of Truvada for PrEP for years.
The CDC waged a successful defense of its patent in Europe, strengthening its case that its patents are legitimate, Morten said. Gilead’s Truvada patent expires in 2021; it could be at least two more years before Gilead faces lower-cost competition in the United States.
इंडिया ताज़ा खबर, इंडिया मुख्य बातें
Similar News:आप इससे मिलती-जुलती खबरें भी पढ़ सकते हैं जिन्हें हमने अन्य समाचार स्रोतों से एकत्र किया है।
Duke settles research misconduct case, agrees to pay U.S. government $112.5 millionDuke University agreed to pay the federal government $112.5 million to settle a lawsuit alleging a research technician falsified data for years to get funding from federal agencies.
और पढो »
Tax Changes Hit Overseas Profits of Some U.S. CompaniesP&G and other multinational companies warn that the new tax system, meant to help them compete in foreign markets and create domestic jobs, could instead put them at a disadvantage globally and reduce their incentive to invest at home.
और पढो »
Apple Really Wants You To Know It’s Good At Privacy, Unlike Those Other CompaniesUser privacy was front and center at Apple’s announcement of new streaming, news, and credit card services.
और पढो »
Tesla just launched the Model Y — here's why it's the company's most important carThe Tesla Model Y is a crossover SUV, and that's the hottest segment in the car business these days.
और पढो »
US companies are going public later and later and it's having a major impact on investingUS companies are opting to go public much later than they did in the past which is having a major impact on investing trends and the behaviour of VCs.
और पढो »
MLB notebook: A's 1B Olson out after hand surgeryOakland Athletics first baseman Matt Olson underwent surgery on his right hand F...
और पढो »
Ichiro says goodbye to adoring fans; Mariners beat A's in 12Ichiro Suzuki was showered with cheers and chants Thursday night while taking his final bow in a magnificent career that lasted nearly three decades when the Seattle Mariners beat the Oakland Athletics 5-4 in 12 innings. The 45-year-old Ichiro went 0 for 4 in the second game of the Major...
और पढो »
China to cut time for patent review by 15 percent: XinhuaChina will reduce the time needed for patent review by at least 15 percent in 20...
और पढो »